Tien-Li Lee
Founder at Aardvark Therapeutics, Inc.
Net worth: 1 213 $ as of 2024-04-29
Profile
Tien-Li Lee has founded Aardvark Therapeutics, Inc. in 2017, where he currently holds the position of Chief Executive Officer & Director.
He was previously the Chief Strategy Officer at NantKwest, Inc. from 2014 to 2017.
Dr. Lee also held several former positions, including Director at SCILEX Pharmaceuticals, Inc. from 2018 to 2023, Independent Director at Scilex, Inc. from 2019 to 2022, and Independent Director at Scilex Holding Co. from 2022 to 2023.
Dr. Lee received an undergraduate degree from the University of California, Berkeley, and a doctorate degree from the University of California San Diego.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
SCILEX HOLDING COMPANY
0.00% | 2023-03-05 | 1,409 ( 0.00% ) | 1 213 $ | 2024-04-29 |
Tien-Li Lee active positions
| Companies | Position | Start |
|---|---|---|
Aardvark Therapeutics, Inc.
 Aardvark Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aardvark Therapeutics, Inc. operates as a biotechnology company. It engages in the development of a novel small molecule therapeutics for obesity and metabolic diseases. The company was founded by Tien Lee in 2017 and is headquartered in San Diego, CA. | Founder | 2016-12-31 |
Former positions of Tien-Li Lee
| Companies | Position | End |
|---|---|---|
SCILEX Pharmaceuticals, Inc.
 SCILEX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SCILEX Pharmaceuticals, Inc. engages in the development and commercialization of pharmaceutical products. It acquires late-stage clinical development and sales and marketing of generic and branded generic products. Its product includes ZTlido. The company was founded by Anthony P. Mack and William Pedranti in 2011 and is headquartered in Berwyn, PA. | Director/Board Member | 2023-08-26 |
| SCILEX HOLDING COMPANY | Director/Board Member | 2023-08-26 |
Scilex, Inc.
 Scilex, Inc. Pharmaceuticals: MajorHealth Technology Scilex, Inc. engages in the acquisition, development, and commercialization of non-opioid pain management products for the treatment of acute and chronic pain. The company is headquartered in Paolo Alto, CA. | Director/Board Member | 2022-10-31 |
| IMMUNITYBIO, INC. | Corporate Officer/Principal | 2017-02-28 |
Training of Tien-Li Lee
| University of California, Berkeley | Undergraduate Degree |
| University of California San Diego | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| SCILEX HOLDING COMPANY | Health Technology |
| Private companies | 4 |
|---|---|
NantKwest, Inc.
 NantKwest, Inc. BiotechnologyHealth Technology NantKwest, Inc. engages in the research and development of immunotherapies. It uses natural killer cells to treat cancer, infectious diseases, and inflammatory diseases. The company was founded by Gary N. Keller and Hans Georg Klingemannon October 7, 2002 and is headquartered in San Diego, CA. | Health Technology |
SCILEX Pharmaceuticals, Inc.
SCILEX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SCILEX Pharmaceuticals, Inc. engages in the development and commercialization of pharmaceutical products. It acquires late-stage clinical development and sales and marketing of generic and branded generic products. Its product includes ZTlido. The company was founded by Anthony P. Mack and William Pedranti in 2011 and is headquartered in Berwyn, PA. | Health Technology |
Scilex, Inc.
Scilex, Inc. Pharmaceuticals: MajorHealth Technology Scilex, Inc. engages in the acquisition, development, and commercialization of non-opioid pain management products for the treatment of acute and chronic pain. The company is headquartered in Paolo Alto, CA. | Health Technology |
Aardvark Therapeutics, Inc.
Aardvark Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aardvark Therapeutics, Inc. operates as a biotechnology company. It engages in the development of a novel small molecule therapeutics for obesity and metabolic diseases. The company was founded by Tien Lee in 2017 and is headquartered in San Diego, CA. | Health Technology |
- Stock Market
- Insiders
- Tien-Li Lee
